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Introduction   
         Science has presented us with a hope called „stem cell research‟ which may 
provide us with answers which have so long been beyond our grasp. The stem cells are 
the powerful and unique cells that can multiply several times and depending on the 
surrounding environment can form specific desired tissue or organ. This has the 
potential to provide solutions for several incurable diseases or injuries. 
Stem cell research is directed towards perfecting the art of using one‟s own 
cells to repair that part of the body which has become affected due to a particular 
disease. The stem cells by virtue of their properties play an important role in the 
normal development of the organs, the system and normal day to day repair. One of 
the major sources of stem cells which are not only economical, procedurally safe, 
controversy free and ease of harvesting is the dental stem cells. The stem cells can 
now be harvested, made to multiply, stored and utilized whenever required in future. 
This is similar to the practice of banking where one deposits money, multiplies it, 
stores it and hence the term „stem cell banking‟. 
The term “tissue engineering” was coined at a National Science Foundation 
(N.S.F.) bioengineering meeting in Washington D.C., in 1987. At a subsequent N.S.F. 
sponsored workshop, it was formally defined as “ the application of principles and 
methods of engineering and life sciences, to obtain a fundamental understanding of 
structural and functional relationships in novel and pathological mammalian tissues, 
and the development of biological substitutes to restore, maintain or improve tissue 
function” (Shalak & Fox, 1988). 
To successfully achieve this goal, the scientist/researchers need: 
Tooth-related cells from each patient, preferably isolated stem cells from the 
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Abstract      
                         
Tissue Engineering is one of the most fascinating areas of  contemporary biology. Research in 
this field continues to advance knowledge about how an organism develops from a single 
cell and how healthy cells replace damaged cells in adult organisms. Stem cells are the cells 
with the ability to divide for indefinite periods in culture and to give rise to specialized cells. 
They have the potential to develop into many different cell types in the body during early life  
and growth. In addition, in many tissues they serve as a sort of internal repair system, 
dividing essentially without limit to replenish other cells as long as the person or animal is 
still alive. 
Along with the correct concentration of scaffold and growth factors,  stem cell can do 
wonders for the treatment options available for the patient. Tissue engineering in 
Endodontics is both exciting and promising and the future would only see an increase in this 
interdisciplinary field. 
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To successfully achieve this goal, the 
scientist/researchers need: 
Tooth-related cells from each patient, preferably isolated 
stem cells from the corresponding teeth tissues that are 
endowed with Odontogenic potential.  Culture 
techniques that permit a fast expansion that would yield 
the needed cell quantities to condition the 
microenvironment and allow for cell-cell interactions that 
would lead to purposeful cell differentiation.  An 
adequate microenvironment supporting 3D tooth-like 
growth, leading to the production of a genuine tooth-
like bud or even a tooth replica.   
 
STEM CELLS 
Murray PE et al. (1) in 2007 defined stem cells as, “a 
cell that has the ability to continuously divide and 
produce progeny cells that differentiate (develop) into 
various other types of cells or tissues”. 
Bluteau G et al (2) in 2008, defined stem cells as, “a 
cell that can reproduce unaltered daughters and, 
furthermore has the ability to generate cells with 
different and more restricted properties”. 
Stem cells differ from other kinds of cells in the 
body. All stem cells, regardless of their source, have 
three general properties: they are capable of dividing 
and renewing themselves for long periods; they are 
unspecialized; they can choose to become one of the 
many different types of cells present in the body based 
on signals from their environments. Unspecialized stem 
cells can give rise to side specialized cells including heart 
muscle cells, blood cells, or nerve cells. They do this by 
coordinating their gene expression in an elaborate and 
complex patterning many generations of cells. 
Adult stem cells are quiescent, slow-cycling, 
undifferentiated cells, which are surrounded by 
neighboring cells and extracellular matrix. Many adult 
tissues (such as the bone marrow, brain and gut) contain 
stem cells. Like ES cells, adult stem cells can make 
identical copies of themselves for long periods of time 
(self-renewal). At the same time, they can give rise to 
mature cell types that have characteristic shapes and 
side specialized functions. Stem cells typically generate 
an intermediate cell type(s) before they achieve their 
fully differentiated state. The intermediate cell is called a 
progenitor cell. Progenitor cells are partly differentiated 
cells in the sense that they are committed to a particular 
cell lineage and, upon division, and give rise to 
differentiated cells. 
PROPERTIES OF THE STEM CELLS 
 
Plasticity: 
 „Plasticity of the stem cells has been defined as 
the ability to produce cells of different tissues‟ 
(1).  
 Stem cells are divided into totipotent, 
pluripotent and multipotent according to their 
plasticity. Embryonic stem cells show a greater 
plasticity hence is more valuable for developing 
new therapies. 
 Undifferentiated cells which can respond to 
appropriate signals. 
 Ability to self replicate. 
 Maintain the multiple differentiations potential. 
 Proliferation properties. 
 
SOURCE OF THE CELLS  
1) Autologous cells (the host‟s own cells) 
2) Allogenic cells (cells from a donor) 
3) Xenogenic cells (cells from a different species) 
4) Stem cells: either allogenic (fetal or adult   
derived) or autologous (adult derived). 
It is often assumed that the use of autologous cells 
implies minimal manipulation and maximum safety for 
the host because of the use of the host‟s own cells. This 
is not entirely correct as culture processes and reagents 
can alter cells, regardless of their origin. 
When allogenic cells are used, the potential for immune 
response and disease transmission must be considered.  
Xenogenic stem cells have been isolated by Iohara K et 
al. (3) in 2006
 
and Cheng PH et al. (4) in 2008
 
from 
porcine and chimpanzees respectively. 
Association of Epithelial and Mesenchymal Stem Cells  
Since teeth are formed from two different tissues, 
building a tooth logically requires the 
association/cooperation of odontogenic mesenchymal 
and epithelial cells. The recombination of dissociated 
dental epithelial and mesenchymal tissues leads to tooth 
formation both in vitro and in vivo.  
SCAFFOLDS 
Tissue engineering inherently involves recreation 
of a 3-dimensional(3-D) tissue structure from a source of 
cells derived from an endogenous source in the patient 
(e.g. bone wound healing) or from an exogenous source 
like a donor (e.g. skin). Biomaterials (scaffolds) are used 
to guide the organization, growth and differentiation of 
cells in the process of forming functional tissue and 
provide both physical and chemical signals. The 
interaction of the scaffold with stem cell population is of 
great importance in guiding the size shape and 
differentiation of bioengineered dental tissues. 
These provide a physiochemical and biological 
three dimensional micro environments for cell growth 
and differentiation, promoting cell adhesion and 
migration and serve as a carrier for morphogens and 
delivery vehicle to the specific sites in the body. It should 
be effective for transport of nutrients, oxygen and waste 
products. A Scaffold matrix should be highly porous with 
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an adequate pore size to facilitate cell seeding and 
diffusion throughout the whole structure of both cells 
and nutrients and should be as biocompatible as much 
possible to reduce tissue toxicity. Biodegradability is an 
essential requirement as it should not require surgical 
excision. It should gradually degrade and be replaced by 
regenerative tissue, retaining features of the final tissue 
structure. The rate of degradation of scaffold matrix and 
new tissue formation should coincide as much as 
possible to achieve successful regeneration.  
Scaffolds should be able to support and guide 
the cell growth and the development of new tissues. The 
matrix should be able to withstand forces and maintain a 
potential space for tissue development and should 
provide a controlled vehicle for gene and protein 
delivery. A large surface area to volume ratio is desirable 
to allow delivery of high density cells. It should 
encourage cell migration and differentiation. The matrix 
should allow rapid colonization by cells of the desired 
phenotype and also neovascularisation once implanted 
into the defect. The matrix can also serve as a regulator 
of cell function through its interaction with other cell 
receptors.   These may include antibiotics to prevent 
bacterial growth 
GROWTH FACTORS 
Growth factors have been described by Murray PE, 
Gracia-Godoy F and Hargreaves KM in 2007(1)
 
as 
proteins that bind to receptors on the cell and induce 
cellular proliferation and/or differentiation. Many growth 
factors are quite versatile, simulating cellular division in 
numerous cell types, while others are more cell specific. 
The growth factors that play an important role in 
endodontic regeneration are:  
o Platelet derived growth factor (P.D.G.F.),  
o Insulin-like growth factor (I.G.F.),  
o Transforming Growth Factor- β (T.G.F.-β), 
o Fibroblast Growth Factor, 
o Bone Morphogenetic Proteins (B.M.P.s). 
 
1) PLATELET DERIVED GROWTH FACTOR (PDGF): 
FORMS: Consequently, PDGF can exist either as a 
heterodimer (AB) or as a homodimer (AA, AB). These 3 
isoforms of PDGF have unique binding properties for 
PDGF receptor sub-units, α and β, found on the cell 
membrane. 
EFFECTS: The primary effect of PDGF is that of a 
mitogen- initiating cell division. Thus, it has been 
characterized as a competence factor, i.e. a growth factor 
that makes a cell competent for cell division. A 
progression factor, such as I.G.F.-1, is then necessary to 
induce mitosis. PDGF also causes replication of 
endothelial cells, causing budding of new capillaries 
(angiogenesis).  
2) INSULIN-LIKE GROWTH FACTORS (IGF-I, II): 
- They are peptide growth factors with biochemical and 
functional similarities to insulin. 
- Bone cells produce and respond to IGF‟s, and bone is a 
storage house for these factors in their inactive form. 
- They are mitogens, and in fibroblastic systems appear 
as progression factors. In bone cell systems, they 
stimulate both proliferation of pre-osteoblasts, as well as 
the differentiation of osteoblasts, including Type I 
collagen synthesis. Thus, IGF increases both the number 
of cells synthesizing bone, as well as amount of extra-
cellular matrix deposited by each cell. 
3) TRANSFORMING GROWTH FACTOR-β: 
- It is a multifactorial growth factor, structurally related 
to B.M.Ps, but functionally quite different. - It has been 
shown to be chemotactic for bone cells, and may 
increase or decrease their proliferation depending upon 
the differentiation state of the cells, culture conditions 
and concentration of TGF-β applied.- In-vivo, it produces 
new cartilage and / or bone, if injected in proximity to 
bone; however, it does not induce new bone formation 
when implanted away from a bony site.- In spite of its 
effects on the augmentation of bone, no positive data 
have been reported on in-vivo healing in a periodontal 
setting. 
4) FIBROBLAST GROWTH FACTORS: 
- They are family of at least 9 related gene products of 
which 2 major members are acidic FGF (a-FGF or FGF-1) 
and basic FGF (b-FGF or FGF-2). 
- It can stimulate endothelial cells and periodontal 
ligament cell migration and proliferation, as well as 
stimulation of bone cell replication.- b-FGF is more 
potent than a-FGF and may act via stimulation of other 
growth factors like TGF-β. 
5) BONE MORPHOGENETIC PROTEINS (BMPs)
 
: 
Bone morphogenic proteins are secreted by the oral 
epithelium layer (oral ectoderm) during early stages of 
odontogenesis. (Dental lamina).  
HURDLES 
Manufacturing concerns: For tissue engineering to help 
alleviate clinical problems,
 
it is necessary for tissue-
engineered products to be manufactured
 
reliably. This 




Ethical concerns: There are at least two major ethical 
concerns related
 
to tissue-engineered products. The first, 
tissue procurement,
 
for many tissue-engineered products 
(such as skin equivalents
 
and bioartificial organs), viable 
cells are an essential component.
 
Unless a patient‟s own 
cells can be amplified in an adequate
 
and timely manner, 
enabling them to be used in the tissue-engineered
 
device (that is, a cell autograft), then cells must be 
derived
 
from another tissue. 
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Another risk is
 
that an animal (in this case, porcine) virus 
might successfully
 
overcome the human species barrier, 
perhaps mutate, and result
 
in a serious human disease.  
Later Yelick and Vacanti in 2006(5) classified the existing 
challenges into two broad categories, Identification and 
characterization of suitable dental progenitor cell 
populations and the development of methods to 
reproducibly manipulate dental progenitor cells to 
bioengineer dental tissues and whole teeth of 
predetermined size and shape in a timely fashion. 
Secondly the formation of the root of a bioengineered 
tooth crown. 
Nor JE in 2006 (6) stated that the several challenges 
before a successful functional dental pulp can be 
effectively and safely engineered in patients: 
1. A clinically feasible way of delivering the scaffold 
(with or without cells) needs to be found, along 
with morphogenic signals to the root canal and 
pulp chamber. 
2. A strategy for inducing angiogenesis will need to 
be developed and characterized. The engineered 
pulp will have to be vascularized to allow the 
survival of the cells and sustainability of the pulp 
tissue over time. 
3. The correct morphogenic signals, as well as the 
timing and sequence of their use, will have to be 
identified.  
Nakashima M and Akamine A in 2005 (7) described the 
importance and need for vascularization and a good 
innervations for the tissue engineered or even a healthy 
pulp for that matter. They explained that the vascular 
system in the dental pulp plays a role in nutrition, 
oxygen supply and as a conduit for removal of metabolic 
waste. The innervation of pulp plays a critical role in the 
homeostasis of the dental pulp. Invasion of immune and 
inflammatory cells into sites of injury in the pulp is 
stimulated by sensory nerves. Growth factors like bone 
morphogenic protein and vascular endothelial growth 
factor have shown encouraging results in the nervous 
regeneration and angiogenesis. The increasing interest in 
tissue engineering of tooth must take in account neuro-
pulpal interactions and nerve regenerations. 
CONCLUSION 
Stem cell research and scaffolding are now the buzz 
words in the basic science pulp researches. The 
endodontic community needs to thus enhance its clinical 
understanding of the vital pulp and dentin and embrace 
new treatment modalities. 
Several regenerative techniques have been described, 
proposed therapies involving stem cells, growth factors 
and scaffolds. Each technique has its own advantages, 
disadvantages, some techniques still in a hypothetical 
stage or in an early stage of development. The 
regenerative therapies will revolutionize the future 
endodontics with the synergistic confluence of advances 
in signaling pathways underlying morphogenesis and 
lineage stem/ progenitor cells by morphogens such as 
BMPs and synthetic scaffolds. 
As we enter an exciting and a promising new era where 
the diverse fields of tissue engineering, material science, 
nanotechnology and stem cell biology have converged 
synergistically to provide unprecedented opportunities 
to characterize and manipulate signaling cascades 
regulating tissue and organ regeneration. 
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